Literature DB >> 30037416

A report on the status of vaccination in Europe.

Shazia Sheikh1, Eliana Biundo2, Soizic Courcier3, Oliver Damm4, Odile Launay5, Edith Maes6, Camelia Marcos7, Sam Matthews8, Catherina Meijer9, Andrea Poscia10, Maarten Postma11, Omer Saka12, Thomas Szucs13, Norman Begg14.   

Abstract

Vaccine policy, decision processes and outcomes vary widely across Europe. The objective was to map these factors across 16 European countries by assessing (A) national vaccination strategy and implementation, (B) attributes of healthcare vaccination systems, and (C) outcomes of universal mass vaccination (UMV) as a measure of how successful the vaccination policy is. A. Eleven countries use standardised assessment frameworks to inform vaccine recommendations. Only Sweden horizon scans new technologies, uses standard assessments, systematic literature and health economic reviews, and publishes its decision rationale. Time from European marketing authorisation to UMV implementation varies despite these standard frameworks. Paediatric UMV recommendations (generally government-funded) are relatively comparable, however only influenza vaccine is widely recommended for adults. B. Fourteen countries aim to report annually on national vaccine coverage rates (VCRs), as well as have target VCRs per vaccine across different age groups. Ten countries use either electronic immunisation records or a centralised registry for childhood vaccinations, and seven for other age group vaccinations. C. National VCRs for infant (primary diphtheria tetanus pertussis (DTP)), adolescent (human papillomavirus (HPV)) and older adult (seasonal influenza) UMV programmes found ranges of: 89.1% to 98.2% for DTP-containing vaccines, 5% to 85.9% for HPV vaccination, and 4.3% to 71.6% for influenza vaccine. Regarding reported disease incidence, a wide range was found across countries for measles, mumps and rubella (in children), and hepatitis B and invasive pneumococcal disease (in all ages). These findings reflect an individual approach to vaccination by country. High VCRs can be achieved, particularly for paediatric vaccinations, despite different approaches, targets and reporting systems; these are not replicated in vaccines for other age groups in the same country. Additional measures to improve VCRs across all age groups are needed and could benefit from greater harmonisation in target setting, vaccination data collection and sharing across EU countries.
Copyright © 2018 GlaxoSmithKline Biologicals SA. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Coverage; Decision-making; Europe; Performance; Policy; Vaccination

Mesh:

Year:  2018        PMID: 30037416     DOI: 10.1016/j.vaccine.2018.06.044

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  36 in total

1.  Mandatory Vaccination in Europe.

Authors:  Olivia M Vaz; Mallory K Ellingson; Paul Weiss; Samuel M Jenness; Azucena Bardají; Robert A Bednarczyk; Saad B Omer
Journal:  Pediatrics       Date:  2020-01-13       Impact factor: 7.124

2.  Adult Vaccination in the United Arab Emirates-A Physicians' Knowledge and Knowledge Sources Study.

Authors:  Hiba J Barqawi; Kamel A Samara; Mahmoud S Hassan; Firas B Amawi
Journal:  Front Public Health       Date:  2022-04-14

Review 3.  [Mass vaccinations against COVID-19 through the use of technologies for the management of appointment scheduling and data of large volumes of vaccinated].

Authors:  Alicia K Rodas-Martinez; Josue R Altamirano-Yupanqui
Journal:  Vacunas       Date:  2022-07-19

4.  Recommending immunizations to adolescents in Turkey: a study of the knowledge, attitude, and practices of physicians.

Authors:  Gizem Kara Elitok; Lida Bulbul; Sibel Baktır Altuntas; Bülent Altuntas; Gözde Günindi; Mustafa Haltaş; Ahmet Yuvarlan; Dilek Toprak; Ali Bulbul
Journal:  Hum Vaccin Immunother       Date:  2020-02-10       Impact factor: 3.452

5.  Age-appropriate vaccination coverage and its determinants for the polio containing vaccine 1-3 and measles-containing vaccine doses in Zhejiang province, China: A community-based cross-sectional study.

Authors:  Yu Hu; Yaping Chen; Ying Wang; Hu Liang; Huakun Lv
Journal:  Hum Vaccin Immunother       Date:  2020-02-12       Impact factor: 3.452

6.  The State of Vaccine Confidence in Poland: A 2019 Nationwide Cross-Sectional Survey.

Authors:  Filip M Furman; Wojciech Stefan Zgliczyński; Mateusz Jankowski; Tomasz Baran; Łukasz Szumowski; Jarosław Pinkas
Journal:  Int J Environ Res Public Health       Date:  2020-06-24       Impact factor: 3.390

Review 7.  Human Papillomavirus Infections, Cervical Cancer and MicroRNAs: An Overview and Implications for Public Health.

Authors:  Michela Lucia Sammarco; Manuela Tamburro; Alessandra Pulliero; Alberto Izzotti; Giancarlo Ripabelli
Journal:  Microrna       Date:  2020

8.  A survey of 20-year-old Japanese women: how is their intention to undergo cervical cancer screening associated with their childhood HPV vaccination status?

Authors:  Reisa Kakubari; Tomomi Egawa-Takata; Yutaka Ueda; Yusuke Tanaka; Asami Yagi; Akiko Morimoto; Yoshito Terai; Masahide Ohmichi; Tomoyuki Ichimura; Toshiyuki Sumi; Hiromi Murata; Hidetaka Okada; Hidekatsu Nakai; Noriomi Matsumura; Kiyoshi Yoshino; Tadashi Kimura; Junko Saito; Risa Kudo; Masayuki Sekine; Takayuki Enomoto; Yorihiko Horikoshi; Tetsu Takagi; Kentaro Shimura
Journal:  Hum Vaccin Immunother       Date:  2020-07-30       Impact factor: 3.452

Review 9.  Relevance of Human Papillomaviruses in Head and Neck Cancer-What Remains in 2021 from a Clinician's Point of View?

Authors:  Markus Hoffmann; Elgar Susanne Quabius
Journal:  Viruses       Date:  2021-06-18       Impact factor: 5.048

10.  Human Papillomavirus (HPV) Vaccine Knowledge, Awareness and Acceptance among Dental Students and Post-Graduate Dental Residents.

Authors:  Steven Kent Mann; Karl Kingsley
Journal:  Dent J (Basel)       Date:  2020-05-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.